Details for Patent: RE46965
✉ Email this page to a colleague
Which drugs does patent RE46965 protect, and when does it expire?
Patent RE46965 protects HALAVEN and is included in one NDA.
This patent has thirty-eight patent family members in fourteen countries.
Summary for Patent: RE46965
Title: | Intermediates for the preparation of analogs of Halichondrin B |
Abstract: | The present invention provides macrocyclic compounds, synthesis of the same and intermediates thereto. Such compounds, and compositions thereof, are useful for treating or preventing proliferative disorders Formula (F-4). ##STR00001## |
Inventor(s): | Austad; Brian (Tewksbury, MA), Chase; Charles E. (Londonderry, NH), Fang; Francis G. (Andover, MA), Calkins; Trevor (Stoughton, WI), Lewis; Bryan M. (North Brunswick, NJ) |
Assignee: | Eisai R&D Management Co., Ltd. (Tokyo, JP) |
Application Number: | 13/924,892 |
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent RE46965
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eisai Inc | HALAVEN | eribulin mesylate | SOLUTION;INTRAVENOUS | 201532-001 | Nov 15, 2010 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: RE46965
PCT Information | |||
PCT Filed | June 03, 2005 | PCT Application Number: | PCT/US2005/019669 |
PCT Publication Date: | December 15, 2005 | PCT Publication Number: | WO2005/118565 |
International Family Members for US Patent RE46965
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2005250487 | See Plans and Pricing | |||
Canada | 2567984 | See Plans and Pricing | |||
Canada | 2822994 | See Plans and Pricing | |||
Canada | 2935786 | See Plans and Pricing | |||
Canada | 3028453 | See Plans and Pricing | |||
China | 101899026 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |